Target validation for genomics using peptide‐specific phage antibodies: A study of five gene products overexpressed in colorectal cancer

Genomic approaches are providing a wealth of information on differential gene expression in cancer. To identify the most interesting genes amongst the many identified, high‐throughput methods for analysis of genes at the translational level are required. We have used a rapid method for the in vitro selection of antibodies to peptide antigens for the generation of probes to 5 gene products that we have found to be overexpressed in colorectal cancer. The rationale of our study was to select a non‐immune phage displayed human antibody library on peptides designed from the coding regions of the gene sequences and to verify whether such antibodies would be suitable probes for the parental protein in immunohistochemical and Western blot analysis. After the generation of a profile of genes overexpressed in primary colorectal cancer (CRC) we selected 5 genes, Ese‐3b, Fls353, PBEF, SPARC and Smad5 for a more detailed analysis using phage display‐derived antibodies. For these 5 antigens we designed 14–20 amino acid peptides predicted to be exposed on the surface of the parental protein. Selection of a large phage displayed antibody library resulted in specific antibodies for 6 of 8 different peptides with between 2 and 15 different antibodies isolated per peptide. Of 20 antibodies tested, 2 antibodies recognized the putative parental protein from primary CRC tissue. An antibody specific for a PBEF‐derived peptide (Fab/PBEF‐D4) was shown to recognize a protein product of the expected molecular weight in Western blotting and showed overexpression in n = 6/8 matched tumor/normal protein lysates. Furthermore, in immunohistochemistry this antibody showed restricted staining of the tumor stromal compartment with no detectable staining of epithelial cells. The discovery that PBEF is overexpressed in cancer is unexpected given that the normal function of PBEF is as a cytokine required for the maturation of B cell precursors. We also report on the isolation of an antibody (Fab/SMAD‐50) specific for a Smad5‐derived peptide that showed cytoplasmic staining of epithelial cells in both CRC tumor and matched normal mucosa. Fab/SMAD‐50 also bound to a group of proteins in Western blotting with molecular weights consistent with belonging to the Smad family. These antibodies may be suitable probes for further investigation of the roles of PBEF and Smad5 in cancer. The amenability of phage display to automation suggests that this approach may be developed for implementation on a genomics scale. Indeed, the large‐scale generation of antibody probes that can be used to study protein expression in situ would be of great value in target validation for functional genomics. © 2002 Wiley‐Liss, Inc.

[1]  S. Ognjanovic,et al.  Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. , 2001, Journal of molecular endocrinology.

[2]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[3]  R. Brekken,et al.  SPARC, a matricellular protein: at the crossroads of cell-matrix. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[4]  P. Pavlík,et al.  Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: applications to functional genomics. , 2000, Journal of molecular biology.

[5]  T. Ørntoft,et al.  Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics , 2000, FEBS letters.

[6]  H R Hoogenboom,et al.  Natural and designer binding sites made by phage display technology. , 2000, Immunology today.

[7]  T. Libermann,et al.  ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1* , 2000, The Journal of Biological Chemistry.

[8]  J. Arends,et al.  A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization , 1999, FEBS letters.

[9]  J. Yokota,et al.  Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. , 1999, Genomics.

[10]  P. Hudson Recombinant antibody constructs in cancer therapy. , 1999, Current opinion in immunology.

[11]  C. Heldin,et al.  Expression of Smad proteins in human colorectal cancer , 1999, International journal of cancer.

[12]  Hennie R. Hoogenboom,et al.  A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies* , 1999, The Journal of Biological Chemistry.

[13]  S. Brenner Errors in genome annotation. , 1999, Trends in genetics : TIG.

[14]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[15]  J. Zavadil,et al.  An antisense transcript to SMAD5 expressed in fetal and tumor tissues. , 1999, Biochemical and biophysical research communications.

[16]  S. Rybak,et al.  Single‐chain variable fragments selected on the 57–76 p21Ras neutralising epitope from phage antibody libraries recognise the parental protein , 1999, FEBS letters.

[17]  C. Heldin,et al.  Intracellular signaling of osteogenic protein‐1 through Smad5 activation , 1998, Journal of Cellular Physiology.

[18]  J. Arends,et al.  Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. , 1998, Cancer research.

[19]  C. Harris,et al.  hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors , 1998, Oncogene.

[20]  R. Parwaresch,et al.  p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. , 1997, Blood.

[21]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[23]  Hopp Tp Retrospective: 12 years of antigenic determinant predictions, and more. , 1993, Peptide research.

[24]  G. Winter,et al.  Selection of phage antibodies by binding affinity. Mimicking affinity maturation. , 1992, Journal of molecular biology.

[25]  H R Hoogenboom,et al.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.

[26]  G. Winter,et al.  Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.

[27]  E. Padlan,et al.  Antibody-antigen complexes. , 1988, Annual review of biochemistry.

[28]  J. G. Sutcliffe,et al.  Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product , 1980, Nature.

[29]  K. Scheidtmann,et al.  Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Wall,et al.  Genes expressed during the IFNγ-induced maturation of pre-B cells , 2002 .

[31]  J. Schneider-Mergener,et al.  Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. , 2000, Biopolymers.

[32]  L. Tashima,et al.  Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. , 2000, American journal of obstetrics and gynecology.

[33]  M. Goumans,et al.  Signaling of transforming growth factor-beta family members through Smad proteins. , 2000, European journal of biochemistry.

[34]  T. Hopp Retrospective: 12 years of antigenic determinant predictions, and more. , 1993, Peptide research.

[35]  P. Stern Predicting antigenic sites on proteins. , 1991, Trends in biotechnology.